1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Healthcare BPO Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Healthcare BPO Market, by Provider Service,
8.1.1 Revenue Cycle Management
8.1.1.1. Market Revenue and Forecast (A)
8.1.2. Patient Enrolments
8.1.2.1. Market Revenue and Forecast
8.1.3. Patient Care
8.1.3.1. Market Revenue and Forecast
9.1. Healthcare BPO Market, by Payer Service
9.1.1. Claims Management
9.1.1.1. Market Revenue and Forecast
9.1.2. Product Development & Business Acquisition (PDBA)
9.1.2.1. Market Revenue and Forecast
9.1.3. Member Management
9.1.3.1. Market Revenue and Forecast
9.1.4. Provider Management
9.1.4.1. Market Revenue and Forecast
9.1.5. Care Management
9.1.5.1. Market Revenue and Forecast
9.1.6. Integrated Front-End Services and Back-office Operations
9.1.6.1. Market Revenue and Forecast
9.1.7. Billing and accounts management services
9.1.8.1. Market Revenue and Forecast
9.1.8. HR Services
9.1.8.1. Market Revenue and Forecast
10.1. Healthcare BPO Market, by Life Science Service
10.1.1. Manufacturing
10.1.1.1. Market Revenue and Forecast
10.1.2. R&D
10.1.2.1. Market Revenue and Forecast
10.1.3. Non-Clinical Services
10.1.3.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Provider Service
11.1.2. Market Revenue and Forecast, by Payer Service
11.1.3. Market Revenue and Forecast, by Life Science Service
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Provider Service
11.1.4.2. Market Revenue and Forecast, by Payer Service
11.1.4.3. Market Revenue and Forecast, by Life Science Service
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Provider Service
11.1.5.2. Market Revenue and Forecast, by Payer Service
11.1.5.3. Market Revenue and Forecast, by Life Science Service
11.2. Europe
11.2.1. Market Revenue and Forecast, by Provider Service
11.2.2. Market Revenue and Forecast, by Payer Service
11.2.3. Market Revenue and Forecast, by Life Science Service
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Provider Service
11.2.4.2. Market Revenue and Forecast, by Payer Service
11.2.4.3. Market Revenue and Forecast, by Life Science Service
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Provider Service
11.2.5.2. Market Revenue and Forecast, by Payer Service
11.2.5.3. Market Revenue and Forecast, by Life Science Service
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Provider Service
11.2.6.2. Market Revenue and Forecast, by Payer Service
11.2.6.3. Market Revenue and Forecast, by Life Science Service
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Provider Service
11.2.7.2. Market Revenue and Forecast, by Payer Service
11.2.7.3. Market Revenue and Forecast, by Life Science Service
11.3. APAC
11.3.1. Market Revenue and Forecast, by Provider Service
11.3.2. Market Revenue and Forecast, by Payer Service
11.3.3. Market Revenue and Forecast, by Life Science Service
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Provider Service
11.3.4.2. Market Revenue and Forecast, by Payer Service
11.3.4.3. Market Revenue and Forecast, by Life Science Service
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Provider Service
11.3.5.2. Market Revenue and Forecast, by Payer Service
11.3.5.3. Market Revenue and Forecast, by Life Science Service
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Provider Service
11.3.6.2. Market Revenue and Forecast, by Payer Service
11.3.6.3. Market Revenue and Forecast, by Life Science Service
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Provider Service
11.3.7.2. Market Revenue and Forecast, by Payer Service
11.3.7.3. Market Revenue and Forecast, by Life Science Service
11.4. MEA
11.4.1. Market Revenue and Forecast, by Provider Service
11.4.2. Market Revenue and Forecast, by Payer Service
11.4.3. Market Revenue and Forecast, by Life Science Service
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Provider Service
11.4.4.2. Market Revenue and Forecast, by Payer Service
11.4.4.3. Market Revenue and Forecast, by Life Science Service
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Provider Service
11.4.5.2. Market Revenue and Forecast, by Payer Service
11.4.5.3. Market Revenue and Forecast, by Life Science Service
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Provider Service
11.4.6.2. Market Revenue and Forecast, by Payer Service
11.4.6.3. Market Revenue and Forecast, by Life Science Service
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Provider Service
11.4.7.2. Market Revenue and Forecast, by Payer Service
11.4.7.3. Market Revenue and Forecast, by Life Science Service
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Provider Service
11.5.2. Market Revenue and Forecast, by Payer Service
11.5.3. Market Revenue and Forecast, by Life Science Service
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Provider Service
11.5.4.2. Market Revenue and Forecast, by Payer Service
11.5.4.3. Market Revenue and Forecast, by Life Science Service
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Provider Service
11.5.5.2. Market Revenue and Forecast, by Payer Service
11.5.5.3. Market Revenue and Forecast, by Life Science Service
12.1. Accenture (Ireland)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Access Healthcare (US)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Akurate Management Solutions (US)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cognizant (US)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Firstsource Solutions (India)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. GeBBS Healthcare Solutions (US)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Genpact (US)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. HCL Technologies (India)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. IBM Corporation (US)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Infosys BPM (India)
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client